Implementation of [18F]-labeled amyloid brain PET imaging biomarker in the diagnosis of Alzheimer's disease: first-hand experience in Thailand

Nucl Med Commun. 2018 Feb;39(2):186-192. doi: 10.1097/MNM.0000000000000787.

Authors

Tanyaluck Thientunyakit¹, Chakmeedaj Sethanandha¹, Weerasak Muangpaisan², Orasa Chawalparit¹, Kuntarat Arunrungvichian³, Tossaporn Siriprapa¹, Thonnapong Thongpraparn¹, Rujaporn Chanachai¹, Juri Gelovani⁴

Affiliations

¹ Department of Radiology.
² Department of Preventive and Social Medicine, Siriraj Hospital.
³ Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
⁴ Department of Biomedical Engineering, School of Medicine and College of Engineering, Karmanos Cancer Institute, Wayne State University, Michigan, USA.

PMID: 29334579
DOI: 10.1097/MNM.0000000000000787

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Alzheimer Disease / diagnostic imaging*
Alzheimer Disease / metabolism*
Amyloid / metabolism*
Biomarkers / metabolism
Brain / drug effects*
Brain / metabolism*
Fluorine Radioisotopes*
Humans
Isotope Labeling
Neuroimaging
Positron-Emission Tomography*
Thailand

Substances

Amyloid
Biomarkers
Fluorine Radioisotopes
Fluorine-18